Browsing by Author "Ferrer-Marín, Francisca"

Sort by: Order: Results:

  • Genomic classification and outcomes of young patients with polycythemia vera and essential thrombocythemia according to the presence of splanchnic vein thrombosis and its chronology
    Garrote, Marta; López-Guerra, Mónica; García-Pagán, Joan Carles; Arellano-Rodrigo, Eduardo; Ferrer-Marín, Francisca; Hernández-Boluda, Juan Carlos; Bellosillo Paricio, Beatriz; Nomdedeu, Meritxell; Hernández-Gea, Virginia; Triguero, Ana; Guijarro, Francesca; Álamo, José; Baiges Aznar, Anna; Turon, Fanny; Colomer Pujol, Dolors; Cervantes, Francisco; Alvarez-Larrán, Alberto (Springer, 2024)
    To elucidate the role of splanchnic vein thrombosis (SVT) and genomic characteristics in prognosis and survival, we compared patients with polycythemia vera (PV) or essential thrombocythemia (ET) presenting SVT at diagnosis ...
  • Impact of genotype on leukaemic transformation in polycythaemia vera and essential thrombocythaemia
    Alvarez-Larrán, Alberto; Senín Magan, Maria Alicia; Fernández Rodríguez, M. Concepción; Pereira, Arturo; Arellano-Rodrigo, Arturo; Gómez, Montse; Ferrer-Marín, Francisca; Martínez-López, Joaquín; Camacho Díaz, Laura; Colomer Pujol, Dolors; Angona Figueras, Anna; Navarro, Blanca; Cervantes, Francisco; Besses Raebel, Carles; Bellosillo Paricio, Beatriz; Hernández-Boluda, Juan Carlos (Wiley, 2017)
    The influence of driver mutations on leukaemic transformation was analysed in 1747 patients with polycythaemia vera or essential thrombocythaemia. With a median follow-up of 7·2 years, 349 patients died and 62 progressed ...
  • Impact of individual comorbidities on survival of patients with myelofibrosis
    García-Fortes, María; Hernández-Boluda, Juan Carlos; Alvarez-Larrán, Alberto; Raya, José M.; Angona Figueras, Anna; Estrada, Natalia; Fox, Laura; Cuevas, Beatriz; García-Hernández, María C.; Gómez-Casares, Maria-Teresa; Ferrer-Marín, Francisca; Saavedra, Silvana; Cervantes, Francisco; García-Delgado, Regina; Grupo Español de Enfermedades Mieloproliferativas Filadelfia Negativas Gemfin (MDPI, 2022)
    The comorbidity burden is an important risk factor for overall survival (OS) in several hematological malignancies. This observational prospective study was conducted to evaluate the impact of individual comorbidities on ...
  • NLRP3 inflammasome activation and symptom burden in KRAS-mutated CMML patients is reverted by IL-1 blocking therapy
    Hurtado Navarro, Laura; Bellosillo Paricio, Beatriz; García Ávila, Sara; Ferrer-Marín, Francisca (Elsevier, 2023)
    Chronic myelomonocytic leukemia (CMML) is frequently associated with mutations in the rat sarcoma gene (RAS), leading to worse prognosis. RAS mutations result in active RAS-GTP proteins, favoring myeloid cell proliferation ...

Search DSpace

Browse

My Account

In collaboration with Compliant to Partaking